Rehab I Moustafa

5PUBLICATIONS
7CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersIndustrial molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 20, 2026
SOX9 and TNFAIP3 dysregulation in HCV-associated HCC after DAA therapy: insights into post-viral oncogenic memory.

Rehab I Moustafa, Sally Farouk, Hassan Elsayed

|Dec 22, 2024
Correction: Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia.

Heba Shawky, Ashraf A Tabll, Reem M Elshenawy

|Dec 11, 2024
Correction: Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals.

Reem El-Shenawy, Rehab I Moustafa, Naiera M Helmy

|Nov 16, 2024
Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals.

Reem El-Shenawy, Rehab I Moustafa, Naiera M Helmy

|Jan 18, 2024
Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia.

Heba Shawky, Ashraf A Tabll, Reem M Elshenawy

Pageof 1

Frequent Collaborators

4 joint publications

Heba Shawky

4 joint publications

Ashraf A Tabll

4 joint publications

Reem M Elshenawy

4 joint publications

Naiera M Helmy